Gujarat Kidney

INR
112.00
3.35 (3.08%)
BSENSE

Feb 10

BSE+NSE Vol: 13.39 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

13.39 lacs (128.44%) Volume

Shareholding (Dec 2025)

FII

10.47%

Held by 9 FIIs

DII

1.67%

Held by 1 DIIs

Promoter

71.45%

Why is Gujarat Kidney & Super Speciality Ltd falling/rising?

10-Feb-2026

As of 09-Feb, Gujarat Kidney & Super Speciality Ltd's stock price is currently at 109.50, reflecting a decline of 1.88% after a trend reversal from previous gains. Despite positive performance over the past week and month, today's significant opening drop and underperformance relative to its sector have led to the current decrease in price.

As of 09-Feb, Gujarat Kidney & Super Speciality Ltd's stock price is falling, currently at 109.50, which reflects a decrease of 2.1 points or 1.88%. This decline follows a trend reversal after four consecutive days of gains. Notably, the stock opened significantly lower today, with a loss of 5.87%, and reached an intraday low of Rs 105.05. Additionally, the stock has underperformed its sector by 3.59% today.<BR><BR>Despite these negative movements, it is important to note that the stock has shown positive performance over the past week and month, with increases of 5.24% and 6.88%, respectively. However, the current day's performance indicates a shift, as the stock is trading lower than its opening price and has seen more volume traded closer to its low price. The rising investor participation, evidenced by a 106.41% increase in delivery volume on February 6, suggests that while there is interest in the stock, the immediate market reaction has led to a decline in price. Overall, the combination of a significant opening gap down and the current underperformance relative to the sector are key factors contributing to the stock's falling price.

View full answer

Which are the latest news on Gujarat Kidney?

10-Feb-2026
No latest news for Gujarat Kidney found.

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Hospital

stock-summary
Market cap

INR 863 Cr (Micro Cap)

stock-summary
P/E

594.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.42

stock-summary
Return on Equity

79.51%

stock-summary
Price to Book

472.21

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Board Meeting Outcome for Board Meeting Outcome For Board Meeting Hold On 5Th February 2026.

05-Feb-2026 | Source : BSE

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) read with Schedule III to the Listing Regulations this is to inform you that the Board of Directors of the Company at its Meeting held today i.e. on Thursday 5th February 2026 (which commenced at 3:30 p.m. and concluded at 4:30 .p.m.) inter alia has approved the following:- 1) APPROVAL FOR TO MAKE INVESTMENT IN PATEL PHARMACY. 2) APPROVAL FOR TO MAKE INVESTMENT IN PATEL MULTISPECIALITY HOSPITAL AND ICU.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

10-Jan-2026 | Source : BSE

Please find enclosed Certificate under Regulation 74(5) under SEBI (Depositories and Participants) Regulation 2018 for the quarter ended 31st December2025.

Board Meeting Outcome for Outcome Of Board Meeting Hold On 6Th January 2026.

06-Jan-2026 | Source : BSE

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) read with Schedule III to the Listing Regulations this is to inform you that the Board of Directors of the Company at its Meeting held today i.e. on Tuesday 6th January 2025 (which commenced at 5:00 p.m. and concluded at 6:00 .p.m.) inter alia has approved the following:- 1) APPROVAL FOR AQUIRE REMAINING 49% SHARES OF M/S. HARMONY MEDICARE PRIVATE LIMITED AND TO MAKE THEM AS WHOLLY OWNED SUBSIDIARY COMPANY. 2) ACCORDING TO ACQUISITION AGREEMENT AND THE ACQUISITION AGREEMENT-II AND OBJECT OF THE ISSUE OF INITIAL PUBLIC OFFERING THE BOARD OF DIRECTORS APPROVED TO MAKE PART PAYMENT OF RS. 1240 LAKHS AS PURCHASE CONSIDERATION FOR THE ALREADY ACQUIRED ASHWINI MEDICAL CENTRE

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
1.25
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.15%
ROCE (avg)
49.23%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
594
Industry P/E
0
Price to Book Value
472.21
EV to EBIT
675.77
EV to EBITDA
553.49
EV to Capital Employed
332.71
EV to Sales
173.53
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
49.23%
ROE (Latest)
79.51%

Technicals key factors

Indicator
Weekly
Monthly
Icon
No records
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 9 FIIs (10.47%)

Promoter with highest holding

Pragnesh Yashwantsinh Bharpoda (38.16%)

Highest Public shareholder

Craft Emerging Market Fund Pcc-citadel Capital Fund (3.89%)

Individual Investors Holdings

11.57%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Gujarat Kidney"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Gujarat Kidney"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Gujarat Kidney"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Gujarat Kidney"
  }
]
stock-summaryCompany CV
About Gujarat Kidney & Super Speciality Ltd stock-summary
stock-summary
Gujarat Kidney & Super Speciality Ltd
Micro Cap
Hospital
Gujarat Kidney And Super Speciality Limited was incorporated under the name and style of `Vihaan Medicare Private Limited', a private limited company, dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre. Subsequently, the Company name was changed to `Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad.
Company Coordinates stock-summary
Icon
No Company Details Available